Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
betapharm is a leading German generic pharmaceutical company headquartered in Augsburg. Founded in 1993, the company focuses on the marketing and distribution of high-quality generic drugs across a wide range of therapeutic areas, including pain management, cardiovascular diseases, and neurology. In 2006, it was acquired by the Indian multinational pharmaceutical company Dr. Reddy's Laboratories, serving as its primary vehicle for the German market. betapharm is known for its extensive portfolio of prescription and over-the-counter medications and its commitment to providing cost-effective healthcare solutions. The company also operates the beta Institut, which focuses on social-medical research and patient-oriented services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on betapharm.